Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-954
Closed -$231K 420
2022
Q1
$231K Sell
954
-245
-20% -$59.3K 0.01% 397
2021
Q4
$312K Sell
1,199
-171
-12% -$44.4K 0.01% 352
2021
Q3
$361K Sell
1,370
-230
-14% -$62.9K 0.01% 324
2021
Q2
$394K Sell
1,600
-172
-10% -$36.2K 0.01% 328
2021
Q1
$344K Sell
1,772
-170
-9% -$34.1K 0.01% 349
2020
Q4
$413K Buy
1,942
+41
+2% +$8.18K 0.01% 323
2020
Q3
$326K Buy
1,901
+20
+1% +$3.69K 0.01% 342
2020
Q2
$361K Sell
1,881
-114
-6% -$18.7K 0.01% 311
2020
Q1
$294K Sell
1,995
-185
-8% -$29.5K 0.01% 320
2019
Q4
$338K Buy
2,180
+80
+4% +$11.5K 0.01% 362
2019
Q3
$284K Buy
2,100
+150
+8% +$19.7K 0.01% 412
2019
Q2
$238K Sell
1,950
-400
-17% -$44.3K 0.01% 446
2019
Q1
$244K Buy
2,350
+370
+19% +$38.2K 0.01% 477
2018
Q4
$225K Sell
1,980
-250
-11% -$26.8K 0.01% 472
2018
Q3
$257K Sell
2,230
-230
-9% -$25.2K 0.01% 515
2018
Q2
$255K Buy
2,460
+50
+2% +$5.06K 0.01% 519
2018
Q1
$237K Buy
2,410
+10
+0.4% +$945 0.01% 529
2017
Q4
$203K Buy
+2,400
New +$198K 0.01% 581

Other funds holding RMD

Conning Inc's RMD Position: Q2 2022 in Review

Conning Inc sold out of ResMed (RMD) in Q2 2022, closing a stake of 954 shares — an estimated $231K sold.

Conning Inc first reported a position in RMD in Q4 2017 and held it in 18 quarters. The position peaked at $413K in Q4 2020. 676 funds tracked by Wall St. Rank hold RMD as of Q2 2022.

  • Conning Inc reported no remaining ResMed position as of Q2 2022 after selling out during the quarter.
  • Conning Inc sold 954 ResMed shares in Q2 2022, an estimated $231K.
  • Conning Inc first reported a position in ResMed in Q4 2017 and held it in 18 quarters.
  • Conning Inc's ResMed position peaked at $413K in Q4 2020.
  • 676 funds tracked by Wall St. Rank held ResMed as of Q2 2022.

Based on Conning Inc's 13F filing for Q2 2022, filed 20 Jul 2022.